The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches Nikhil GuptaNavjot KanwarAbhinav Kanwal REVIEW ARTICLE 18 March 2024 Pages: 1421 - 1433
How can clinicians enhance self-efficacy beliefs in osteoarthritis? An overview of systematic reviews with meta-analysis Javier Martinez-CalderonFrancisco Javier Cano-GarcíaMarta Infante-Cano REVIEW ARTICLE 22 March 2024 Pages: 1435 - 1446
Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry Hiroshi HaradaMasakazu KondoYasuharu Nakashima ORIGINAL ARTICLE 06 January 2024 Pages: 1447 - 1459
Evaluation of the prognostic nutritional index (PNI) as a tool for assessing disease activity in rheumatoid arthritis patients Nuran ÖzHalise Hande GezerMehmet Tuncay Duruöz ORIGINAL ARTICLE 11 March 2024 Pages: 1461 - 1467
Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trial Panagiotis AthanassiouPelagia KatsimbriEMBRACE Study Group ORIGINAL ARTICLE Open access 12 March 2024 Pages: 1469 - 1478
Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters Fangyi LuQilin ChenYunfeng Li ORIGINAL ARTICLE 16 March 2024 Pages: 1479 - 1489
Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia Qi AnRulan MaLan He ORIGINAL ARTICLE 18 March 2024 Pages: 1491 - 1501
Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores Alix BirdLauren Oakden-RaynerLyle J. Palmer ORIGINAL ARTICLE Open access 27 March 2024 Pages: 1503 - 1512
Mendelian randomization study on causal association of FAM210B with drug-induced lupus Yaqi XuRan GaoRenxi Wang ORIGINAL ARTICLE 04 March 2024 Pages: 1513 - 1520
A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus Mengjie ChenJianxin TuLi Sun ORIGINAL ARTICLE 20 March 2024 Pages: 1521 - 1530
Identification of EPSTI1 as a new potential biomarker for SLE based on GEO database Yiying YangHuali ZhangMuyao Guo ORIGINAL ARTICLE 20 March 2024 Pages: 1531 - 1540
A predictive model for premature atherosclerosis in systemic lupus erythematosus based on clinical characteristics Ruyu LiangHaojie XuYin Su Original Article 02 April 2024 Pages: 1541 - 1550
Non-thyroidal disease syndrome in patients with systemic lupus erythematosus: relation to disease inflammatory activity Xue MengAng LvHaiqing Zhang ORIGINAL ARTICLE 05 April 2024 Pages: 1551 - 1558
Increased carotid intima-media thickness in patients with radiographic axial spondyloarthritis compared to controls and associations with markers of inflammation Lucy LawPer LindqvistHelena Forsblad-d’Elia ORIGINAL ARTICLE Open access 06 March 2024 Pages: 1559 - 1570
Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study Kerem AbacarSema Kaymaz-TahraFatma Alibaz-Öner ORIGINAL ARTICLE 02 April 2024 Pages: 1571 - 1578
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia Geoffrey LittlejohnJoanna LeadbetterPeter Youssef ORIGINAL ARTICLE Open access 09 March 2024 Pages: 1579 - 1589
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis Proton RahmanIain B. McInnesDennis McGonagle ORIGINAL ARTICLE Open access 12 March 2024 Pages: 1591 - 1604
Efficacy and safety of tofacitinib for chronic plaque psoriasis and psoriatic arthritis: a systematic review and meta-analysis of randomized controlled trials Qianqian DaiYanfeng ZhangChijin Zhang ORIGINAL ARTICLE 22 March 2024 Pages: 1605 - 1613
Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality Sebastián UdryJosé O. LatinoGabriela de Larrañaga ORIGINAL ARTICLE 04 March 2024 Pages: 1615 - 1622
Immune profiling analysis of double-negative T cells in patients with systemic sclerosis Dongdong ZhangMihribangvl AlipDandan Wang ORIGINAL ARTICLE 04 March 2024 Pages: 1623 - 1634
Phenotypes of patients with systemic sclerosis in the Chinese Han population: a cluster analysis Yaqi ZhaoWei XuQingrui Yang ORIGINAL ARTICLE 15 March 2024 Pages: 1635 - 1646
Divergent perspectives: exploring the relationships between St. George’s Respiratory Questionnaire and outcome measures in systemic sclerosis–associated interstitial lung disease Enes BasaranDuygu Temiz KaradagAyse Cefle ORIGINAL ARTICLE 04 April 2024 Pages: 1647 - 1656
Functional capacity, physical activity, and arterial stiffness in patients with systemic sclerosis Aylin TanriverdiBuse Ozcan KahramanSema Savci ORIGINAL ARTICLE 04 April 2024 Pages: 1657 - 1664
Clinical features and risk factors of primary Sjögren’s syndrome complicated with severe pneumonia: a case–control study Bo CaiZhiliang GuoXianming Long ORIGINAL ARTICLE 21 March 2024 Pages: 1665 - 1674
The value of MRI-based radiomics for evaluating early parotid gland injury in primary Sjögren’s syndrome Lu LuTiantian DaiGuoqing Li Original Article 27 March 2024 Pages: 1675 - 1682
Non-invasive imaging for predicting labial salivary gland biopsy outcomes in patients with suspected primary Sjögren syndrome Nan XuXuanhan WangGuoqing Li ORIGINAL ARTICLE 03 April 2024 Pages: 1683 - 1692
Clinical characteristics of patients with connective tissue disease–related interstitial lung disease: a retrospective analysis Seda ColakEmre TekgozSedat Yilmaz ORIGINAL ARTICLE 09 March 2024 Pages: 1693 - 1701
Naifold capillaroscopy in mixed connective tissue disease patients Sylwia OrnowskaMariusz WudarskiMarzena Olesińska ORIGINAL ARTICLE 21 March 2024 Pages: 1703 - 1709
Development and validation of a risk prediction model for valve regurgitation in Behçet’s disease Zixian DengBenhui LiangJianghua Li ORIGINAL ARTICLE 27 March 2024 Pages: 1711 - 1721
Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA): does duration matter? Kai Liang TehLena DasThaschawee Arkachaisri ORIGINAL ARTICLE 05 March 2024 Pages: 1723 - 1733
Coffee intake reduced gout risk by decreasing urate and urea while increasing SHBG levels in plasma: a mediation Mendelian randomization study Tingting QinYuxin ChuQibin Song ORIGINAL ARTICLE 06 March 2024 Pages: 1735 - 1743
Comparison of the efficacy and safety of benzbromarone and febuxostat in gout and hyperuricemia: a systematic review and meta-analysis Fan WuLvyi ChenYimei Du ORIGINAL ARTICLE 16 March 2024 Pages: 1745 - 1754
Gardening/yardwork in people with knee osteoarthritis is not associated with symptom or structural progression over 48 months: data from the Osteoarthritis Initiative Grace H. LoJulieann C. PatariniJeffrey B. Driban ORIGINAL ARTICLE 01 April 2024 Pages: 1755 - 1762
A statistical symptomatic evaluation on SAPHO syndrome from 56 cases of confirmed diagnosis and 352 cases of non-SAPHO involvement Cheng QiuManyu LiLianlei Wang ORIGINAL ARTICLE 06 March 2024 Pages: 1763 - 1775
Respiratory infection risk in primary Sjögren’s syndrome complicated with interstitial lung disease: a retrospective study Hao LiYuebo JinJing He LETTER TO THE EDITOR 14 March 2024 Pages: 1777 - 1777
Letter to the Editor: “Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis” Tianfei YuSiyuan QianMing Li LETTER TO THE EDITOR 06 April 2024 Pages: 1779 - 1781
Raman spectroscopic analysis of joint capsule calcification of the fingers T. L. JansenM. JanssenT. Niessink CLINICAL IMAGE 19 March 2024 Pages: 1783 - 1784
Geiser Sign in a patient with rheumatoid arthritis Daniela OliveiraRaquel Miriam FerreiraCarlos Vaz CLINICAL IMAGE 04 April 2024 Pages: 1785 - 1786
Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry Hiroshi HaradaMasakazu KondoYasuharu Nakashima Correction 15 March 2024 Pages: 1787 - 1791